SI1312667T1 - Probiotiäśni produkti, ki vsebujejo sev l. salivarius - Google Patents

Probiotiäśni produkti, ki vsebujejo sev l. salivarius

Info

Publication number
SI1312667T1
SI1312667T1 SI200130897T SI200130897T SI1312667T1 SI 1312667 T1 SI1312667 T1 SI 1312667T1 SI 200130897 T SI200130897 T SI 200130897T SI 200130897 T SI200130897 T SI 200130897T SI 1312667 T1 SI1312667 T1 SI 1312667T1
Authority
SI
Slovenia
Prior art keywords
lactic acid
acid bacteria
probiotics
digestive tract
effective component
Prior art date
Application number
SI200130897T
Other languages
English (en)
Inventor
Azusa Kato
Seigo Nakaya
Nobuyuki Suzuki
Haruhisa Hirata
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of SI1312667T1 publication Critical patent/SI1312667T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/179—Sakei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SI200130897T 2000-08-25 2001-08-27 Probiotiäśni produkti, ki vsebujejo sev l. salivarius SI1312667T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000254775 2000-08-25
EP01958512A EP1312667B1 (en) 2000-08-25 2001-08-27 Probiotic products containing L. salivarius strain
PCT/JP2001/007312 WO2002016554A1 (fr) 2000-08-25 2001-08-27 Produits probiotiques contenant une bacterie de l'acide lactique

Publications (1)

Publication Number Publication Date
SI1312667T1 true SI1312667T1 (sl) 2009-04-30

Family

ID=18743660

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130897T SI1312667T1 (sl) 2000-08-25 2001-08-27 Probiotiäśni produkti, ki vsebujejo sev l. salivarius

Country Status (9)

Country Link
US (1) US7150986B2 (sl)
EP (1) EP1312667B1 (sl)
JP (1) JP3944076B2 (sl)
AT (1) ATE419331T1 (sl)
AU (1) AU2001280178A1 (sl)
DE (1) DE60137235D1 (sl)
ES (1) ES2316463T3 (sl)
SI (1) SI1312667T1 (sl)
WO (1) WO2002016554A1 (sl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
JP4203855B2 (ja) * 2002-03-29 2009-01-07 株式会社フレンテ・インターナショナル 乳酸菌を有効成分とする生菌製剤および乳酸菌含有食品
JP4212838B2 (ja) 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
JP2005013211A (ja) * 2002-09-27 2005-01-20 Wakamoto Pharmaceut Co Ltd 乳酸菌含有食品組成物
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
US20040197304A1 (en) 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
FR2869622B1 (fr) * 2004-04-28 2008-04-18 Rhodia Chimie Sa Comprimes de micro-organismes pour ensemencement direct
EP1634948A1 (en) * 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
CA2671507A1 (en) * 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutans streptococci
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US20080299098A1 (en) * 2007-04-24 2008-12-04 Chea-Yun Se Broad-Spectrum Antibacterial and Antifungal Activity of Lactobacillus Johnsonii D115
PL210465B1 (pl) * 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2133414A1 (en) 2008-06-11 2009-12-16 Basf Se Uses and methods for preventing and /or treating oral malodour
KR101690090B1 (ko) 2009-07-16 2016-12-27 고쿠리츠다이가쿠호진 히로시마다이가쿠 구강내 질환의 예방, 개선 또는 치료제
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP2013507394A (ja) * 2009-10-09 2013-03-04 プロセラ インコーポレイテッド 自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法
TWI384990B (zh) * 2010-01-15 2013-02-11 Glact Biotech Co Ltd 用於治療胃潰瘍之乳酸菌菌株之食品組成物以及醫藥組成物
JP2012092094A (ja) * 2010-09-30 2012-05-17 Wakamoto Pharmaceutical Co Ltd 油脂中に乳酸菌を含有する口腔用組成物
KR101062555B1 (ko) * 2011-01-11 2011-09-06 광주시농업기술센터 축산용 생균제 조성물 및 그 제조방법
JP5468183B2 (ja) 2011-12-28 2014-04-09 株式会社山田養蜂場本社 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
US10857090B2 (en) * 2013-07-05 2020-12-08 Stellar Biome Inc. Oral compositions
TWI581791B (zh) * 2013-10-01 2017-05-11 行政院國軍退除役官兵輔導委員會高雄榮民總醫院 六羥季銨鹽類治療哺乳動物腸病毒７１型腦炎的用途
TWI577380B (zh) * 2015-01-14 2017-04-11 Lactic acid bacteria composition for the treatment of gastrointestinal disorders
JP6236052B2 (ja) * 2015-11-16 2017-11-22 欽也 斉藤 口内虫歯予防粉及び口内虫歯予防粉の製造方法
JP6190512B1 (ja) * 2016-10-27 2017-08-30 肇 福永 Ｍ細胞を制御する乳酸菌の生成方法
ES2898876T3 (es) 2018-01-26 2022-03-09 Probisearch S L U Composición que comprende una nueva cepa de Lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas
CN109486700A (zh) * 2018-08-31 2019-03-19 石家庄君乐宝乳业有限公司 副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用
KR102251294B1 (ko) * 2018-11-06 2021-05-12 주식회사 메디뉴트롤 락토바실러스 살리바리우스 v133 균주의 사균체를 유효성분으로 함유하는 알코올성 위염의 예방, 개선 또는 치료용 조성물
CN110923172B (zh) * 2019-12-25 2023-05-09 江西仁仁健康微生态科技有限公司 一株具有通便功效和降胆固醇功效的唾液乳杆菌及应用
CN115466699B (zh) * 2022-09-28 2023-03-31 成都大熊猫繁育研究基地 熊猫源唾液乳杆菌及在治疗或预防炎症性肠病中的应用
CN115725456B (zh) * 2022-10-11 2024-06-21 四川大学 一种唾液乳杆菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262442A (en) * 1984-03-09 1989-10-24 Yasuo Kawai Anticariogenic or antiperiodontitic agent
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
ATE207755T1 (de) * 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
CA2354054C (en) * 1998-12-11 2011-04-12 Urex Biotech, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
JP4603116B2 (ja) * 1999-12-02 2010-12-22 わかもと製薬株式会社 乳酸菌含有組成物、医薬及び食品

Also Published As

Publication number Publication date
WO2002016554A9 (fr) 2002-03-28
EP1312667A1 (en) 2003-05-21
EP1312667A4 (en) 2005-01-19
US20030157079A1 (en) 2003-08-21
US7150986B2 (en) 2006-12-19
JP3944076B2 (ja) 2007-07-11
WO2002016554A1 (fr) 2002-02-28
DE60137235D1 (de) 2009-02-12
EP1312667B1 (en) 2008-12-31
ATE419331T1 (de) 2009-01-15
ES2316463T3 (es) 2009-04-16
AU2001280178A1 (en) 2002-03-04

Similar Documents

Publication Publication Date Title
SI1312667T1 (sl) Probiotiäśni produkti, ki vsebujejo sev l. salivarius
EP0986314A4 (en) PROBIOTIC MILKY ACID BACTERIUM FOR THE TREATMENT OF BACTERIAL INFECTIONS ASSOCIATED WITH SIDS
TWI401086B (zh) 胚芽乳酸桿菌及其用途
HUP0100428A2 (hu) Lactobacillus paracasei subsp. paracasei fajhoz tartozó baktériumtörzs, abból élelmiszeripari alkalmazás céljára előállított készítmények, valamint a baktériumtörzset tartalmazó termékek
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
WO2001058465A3 (en) Probiotic therapy for newborns
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
CA2263954A1 (en) Dehydrated food containing lactic acid bacteria
JP2001519144A5 (sl)
HK1066174A1 (en) Lactic acid bacteria and/or bifidobacteria, a composition containing the same and the use thereof
WO2000007606A3 (en) Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
EP0861905A3 (en) Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
GB2376240A (en) Novel lactobacillus paracasei subsp paracasei strain antibacterial against helcobacter pylori and escherichia coli 157H7
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
EP1611796A4 (en) FOOD COMPOSITION
MY140870A (en) Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein
CA2314775A1 (en) Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
Singroha et al. Isolation and characterization of potential probiotic Lactobacillus gasseri strains isolated from different sources
WO2000067583A3 (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
Chawla et al. Safety issues in probiotic use
DeLoach et al. Probiotic for control of Salmonella